Categories: Latest

Cadila Pharma awarded as the Most Preferred Workplace 2023

Ahmedabad, July 05, 2023: Cadila Pharmaceuticals, one of the country’s oldest and largest privately held drug companies, has been recognised as the Most Preferred Workplace for the year 2023. The award was presented to Cadila Pharmaceuticals at a grand function in Mumbai recently, acknowledging Cadila Pharmaceuticals’ commitment to creating an exceptional work environment.

The Most Preferred Workplace 2023 is an initiative spearheaded by Team Marksmen, known for helping organisations and leaders from diverse sectors achieve impactful change through unique brand solutions.

On behalf of Cadila Pharmaceuticals, Mr. Sumit Saluja – Joint President BSBU HR and Mr. Ronak Doshi – Corporate Communication received this esteemed award.

The Most Preferred Workplace award selection process involved an industry-wide consumer study conducted by LeadCap Ventures. Brands were evaluated on various parameters, including employee centricity, organisational purpose, intrapreneurial culture, work-life balance, diversity, equity and inclusion, growth, recognition and rewards, as well as safety & trust.

Cadila Pharmaceuticals is deeply committed to its human resources, recognizing them as the backbone of the organization’s success. The company places immense value on creating a supportive and inclusive work environment that fosters growth, development, and overall well-being. The company strives to empower its employees, encouraging innovation, collaboration, and a strong sense of ownership.

According to Team Marksmen, the evolving landscape of skill development, remote jobs, and freelance opportunities has resulted in individuals seeking greater control over their work-life balance, leading to a rise in job transitions. However, a few organisations have recognised this transition and created best-in-class workplaces and work models, thus ensuring they occupy the pride of place as a Most Preferred Workplace 2023.

Corporate Comm India (CCI Newswire)

The Pharma Times News Bureau

Recent Posts

Lung Cancer in India: Understanding Risk Factors and the Importance of Early Detection

By Dr. Pavan Yadav, Lead Consultant - Interventional Pulmonology & Lung Transplantation, Aster RV Hospital.…

16 hours ago

10 Winter Skin Care Tips Dermatologists Swear By

Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru  Winter weather brings a host…

3 days ago

Fighting Viral Hepatitis in India: Prevention, Risks, and the Path to Better Health

By Dr. Naveen Ganjoo, Senior Consultant - Hepatology & Integrated Liver Care, Aster RV Hospital…

4 days ago

Hon’ble Prime Minister Shri Narendra Modi Inaugurates LyfiusPharma’s Flagship Penicillin-G Facility at Kakinada, Andhra Pradesh

Under the Production Linked Incentive(PLI)scheme, Lyfius Pharma Private Limited(LyfiusPharma) invested ₹2,500 crores in Penicillin-G( Pen-G)facility…

5 days ago

SpOvum® Launches ARTGPT Redefining Patient Support in Assisted Reproductive Technology (ART)

Launched for 1st time in India, ARTGPT is designed to address queries regarding A.R.T treatments Product created…

1 week ago